Bristol Myers Squibb to Participate in the Wolfe Research Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 16, 2022 in New York City. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer, will answer questions about the company at 3:20 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005138/en/

Bristol Myers Squibb

Media:
[email protected]

Investor Relations:
[email protected]

Source: Bristol Myers Squibb

You May Also Be Interested In

• Voltaris Power Acquires Electronic Power Design, Expanding Mission-Critical Power Capabilities
• XRP Price Prediction: Grok and Gemini Target $3.50 as Remittix’s Payments Model Enters the Comparison
• GreenFirst Welcomes More Than $7.5 Million in Ontario Support for Chapleau Modernization and Biomass Innovation